VITROS Anti-HBc IgM

FDA Premarket Approval P030026 S037

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceVITROS Anti-HBc IgM
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantOrtho-Clinical Diagnostics, Inc.100 Indigo Creek Dr.rochester, NY 14626-5101 PMA NumberP030026 Supplement NumberS037 Date Received09/30/2022 Decision Date01/24/2023 Product Code LOM  Advisory Committee Microbiology Supplement Typereal-time Process Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No
Date Received2022-09-30
Decision Date2023-01-24
PMAP030026
SupplementS037
Product CodeLOM 
Advisory CommitteeMicrobiology
Supplement TypeReal-time Process
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination ProductNo
Applicant AddressOrtho-Clinical Diagnostics, Inc.
100 Indigo Creek Dr.
rochester, NY 14626-5101 PMA NumberP030026 Supplement NumberS037 Date Received09/30/2022 Decision Date01/24/2023 Product Code LOM  Advisory Committee Microbiology Supplement Typereal-time Process Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No Combination ProductNo Approval Order Statement  
Approval For Revisions To The Package Insert To Include Information On Biotin Interference.

Supplemental Filings

Supplement NumberDateSupplement Type
P030026Original Filing
S037 2022-09-30 Real-time Process
S036 2019-05-21 30-day Notice
S035 2018-10-16 Normal 180 Day Track No User Fee
S034 2018-02-21 Normal 180 Day Track No User Fee
S033 2018-01-16 30-day Notice
S032 2018-01-09 Normal 180 Day Track No User Fee
S031 2015-10-05 30-day Notice
S030 2015-08-10 30-day Notice
S029 2015-01-16 30-day Notice
S028 2013-09-20 30-day Notice
S027 2012-11-29 30-day Notice
S026 2012-10-17 30-day Notice
S025 2012-01-30 30-day Notice
S024 2011-10-05 Real-time Process
S023 2011-05-19 30-day Notice
S022 2011-05-16 135 Review Track For 30-day Notice
S021 2010-12-08 30-day Notice
S020 2010-10-18 30-day Notice
S019 2009-12-01 Normal 180 Day Track No User Fee
S018 2009-05-22 30-day Notice
S017 2009-03-06 30-day Notice
S016 2009-02-20 Normal 180 Day Track
S015 2008-11-13 Normal 180 Day Track No User Fee
S014 2008-02-27 30-day Notice
S013 2007-03-08 30-day Notice
S012 2007-02-07 Special (immediate Track)
S011 2006-08-21 30-day Notice
S010 2006-05-17 30-day Notice
S009 2005-11-14 30-day Notice
S008 2005-09-30 Special (immediate Track)
S007 2005-06-27 30-day Notice
S006 2005-06-03 30-day Notice
S005 2005-04-07 30-day Notice
S004 2004-12-21 30-day Notice
S003 2004-12-15 30-day Notice
S002 2004-10-26 30-day Notice
S001 2004-05-24 30-day Notice

NIH GUDID Devices

Device IDPMASupp
10758750002795 P030026 028
10758750001194 P030026 028
10758750001187 P030026 028

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.